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https://doi.org/10.1016/j.stemcr.2019.03.003SUMMARYDefinitive hematopoietic stem cells (HSCs) first emerge in the aorta-gonad-mesonephros (AGM) region in both mice and humans.
An ex vivo culture approach has enabled recapitulation and analysis of murine HSC development. Knowledge of early human HSC
development is hampered by scarcity of tissue: analysis of both CFU-C and HSC development in the human embryo is limited.
Here, we characterized the spatial distribution and temporal kinetics of CFU-C development within early human embryonic tissues.
We then sought to adapt the murine ex vivo culture system to recapitulate human HSC development. We show robust expansion
of CFU-Cs and maintenance, but no significant expansion, of human HSCs in culture. Furthermore, we demonstrate that HSCs
emerge predominantly in the middle section of the dorsal aorta in our culture system. We conclude that there are important
differences between early mouse and human hematopoiesis, which currently hinder the quest to recapitulate human HSC develop-
ment ex vivo.INTRODUCTION
Hematopoietic stem cells (HSCs) develop in the aorta-
gonad-mesonephros (AGM) region, marking the onset of
life-long adult hematopoiesis (Ivanovs et al., 2011; Med-
vinsky and Dzierzak, 1996; Mu¨ller et al., 1994). Various
lines of evidence indicate that in both mice and humans,
HSCs mature within intra-aortic hematopoietic clusters
(IAHCs), budding predominantly from the ventral floor
of the dorsal aorta, and co-express endothelial and
hematopoietic markers: CD34, CD144 (VE-cadherin),
CD45, RUNX1 (Ivanovs et al., 2014; Souilhol et al.,
2016; Tavian et al., 1996, 1999; Taylor et al., 2010; Yoko-
mizo and Dzierzak, 2010). In mouse and humans, defini-
tive HSCs, detectable by direct transplantation into adult
recipients, emerge in the AGM region in low numbers
(1 HSC) (Ivanovs et al., 2011; Kumaravelu et al., 2002;
Rybtsov et al., 2016).
Knowledge of the process of HSCmaturation and expan-
sion will be essential for directing the successful develop-
ment of HSCs in vitro. Due to the rarity of suitable embry-
onic material, analysis of early HSC development in
humans has significantly lagged behind mouse studies.
In the mouse, an AGM ex vivo culture system facilitates
recapitulation of HSC development, enables the analysis
of the developing HSC hierarchy and identification of
HSC molecular regulators (Rybtsov et al., 2011, 2014;Stem
This is an open access artiSouilhol et al., 2016; Taoudi et al., 2008). This culture
system, functionally validated by long-term repopulation
transplantation assays, has demonstrated a concealed dra-
matic expansion of immature HSC precursors (pre-HSCs)
that occurs in the mouse AGM region prior to colonization
of the fetal liver (Rybtsov et al., 2016). Evidence of human
precursors of HSCs has not yet been sought. We hypothe-
sized that pre-HSCs also exist in the human AGM and that
their existence could be established using similar culture
conditions to those employed for the maturation of mouse
HSCs.
Understanding the precise location of HSC emergence
will also be fundamental for future investigation of hu-
man embryonic hematopoiesis and ultimately achieving
the generation of HSCs in vitro. Earlier studies in the
human embryo demonstrated that IAHCs, composed of
hematopoietic CD34+CD45+ cells, are found exclusively
in the ventral side of the dorsal aorta (AoV), emerging
at Carnegie stage (CS) 12–13 (27 days post conception
[dpc]) and disappearing by CS17 (39–42 dpc) (Tavian
et al., 1996, 1999). This exclusive location of clusters in
AoV correlates with the detection of HSCs only in AoV
in the human embryo (Ivanovs et al., 2011). We hypoth-
esized that the location of HSCs would also correlate
with the distribution of hematopoietic progenitor cells
in the AGM region. Basic analysis of committed human
myeloid progenitor cells (CFU-Cs) in the human embryoCell Reports j Vol. 12 j 1–13 j May 14, 2019 j Crown Copyright ª 2019 1
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Spatiotemporal Distribution of
Committed Hematopoietic Progenitors in
the Human Embryo
The number and type of CFU-Cs at different
Carnegie stages (CS) are shown for the AGM
region (A), yolk sac (YS) (B), embryonic liver
(EL) (C), and umbilical cord (UC) (D). For
these experiments, embryonic tissue was
staged, dissected, dissociated, and plated
directly into methylcellulose and analyzed
10–14 days later. For AGM, n R 4. For YS,
n = 2 except CS14 where n = 1. For EL, n = 1
except where error bars are shown where n = 4
(CS13) and n = 2 (CS16). For UC, n = 1. Error
bars show the standard error of the mean
(SEM). ee, embryonic equivalent. See also
Figure S1.
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2001). Here, we aimed to advance our understanding of
early human hematopoietic development by temporal
and spatial characterization of CFU-Cs and HSCs gener-
ated during the period of embryonic development be-
tween CS14 and CS17, when definitive HSCs and IAHCs
are detectable in the human AGM region (Ivanovs et al.,
2011; Tavian et al., 1996, 1999). We also aimed to estab-
lish a human AGM culture system, similar to the mouse
system, which would recapitulate the in vivo process
of HSC maturation and potentially reveal the presence
of human pre-HSCs. We focused on a major regulator of
HSC development, stem cell factor (SCF, KIT ligand)
expressed in the AGM region, which efficiently supports
HSC maturation in mouse AGM explants (Rybtsov et al.,
2014; Souilhol et al., 2016).
We present quantitative distribution and growth kinetics
of CFU-C development across hematopoietic tissues. The
analysis of the ex vivo culture of the human AGM regions
showed robust CFU-C expansion, but minimal or no HSC
maturation/expansion. Although we revealed that defini-
tive HSCs emerge predominantly in the middle section
of the dorsal aorta, the failure to establish a productive
human AGM culture system prevents us currently from
gaining insight into human pre-HSC development. We
conclude that despite clear evolutionary conservation of
hematopoietic development across vertebrate species,
some important differences between mouse and human
exist that currently hinder analysis of HSC development
in the human AGM region.2 Stem Cell Reports j Vol. 12 j 1–13 j May 14, 2019RESULTS
Spatial and Temporal Distribution of Hematopoietic
Progenitors in the Early Human Embryo
To establish the spatial and temporal distribution of he-
matopoietic progenitors during early humandevelopment,
we performed CFU-C assays during and just before the
developmental window for HSCs/IAHCs in the human
AGMregion (CS12–17). CFU-Cs in theAGM region showed
a linear increase in total numbers from 75 ± 35 at CS12 to
700 ± 340 at CS17 (Figure 1). In the yolk sac, total CFU-C
numbers remained more constant throughout this period
(400 ± 140 at CS12 and 375 ± 75 at CS17). Meanwhile, in
the embryonic liver, low CFU-C numbers (range, 40–210)
were observed until CS14, followed by a dramatic rise at
CS 15/16 (range, 700–1,100) with a further increase at
CS17 (2,500). CFU-C numbers in the umbilical cord were
low at all stages and fluctuated between 60 (at CS12) and
200 (at CS16). Notably, the size of myeloid colonies from
the AGM region appeared larger than from other embry-
onic tissues (Figure S1).
With regard to colony morphology, CFU-Cs both in the
AGM region and the yolk sac were predominantly granulo-
cyte/macrophage (myeloid) colonies and a sizable fraction
of relatively large erythroid colonies. A slight increase in
erythroid colonies in the yolk sac occurred concurrently
with their peak in the embryonic liver, AGM, and umbilical
cord at CS16, potentially consistent with colonization
of the embryo body with yolk sac progenitors. We also
observed an increased complexity of colonies generated
AB C
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Figure 2. Testing Ex Vivo Culture Sys-
tems for Expansion of Hematopoietic
Progenitors
(A) Human embryos were staged, dissected,
and either dissociated to make aggregates or
cultured as explants at the air-liquid inter-
face. When aggregates were made, aliquots
were taken for the CFU-C assay (typically
0.1 ee). Aggregates were either self-reag-
gregated or co-aggregated with OP9 stromal
cells. All tissues were cultured for 5–7 days
at the air-liquid interface with variable
addition of cytokines/small molecules. After
culture, the tissue was dissociated and in-
jected into sub-lethally irradiated NSG mice.
After culture of both aggregates and ex-
plants, aliquots were taken for the CFU-C
assay (up to 0.1 ee). The images of dissected
tissue depict the lateral view of an AGM
(left), embryonic liver (top right), and yolk
sac (bottom right).
(B–D) Number and type of CFU-Cs before and
after culture using different culture systems;
explant culture for 7 days (B), self-re-
aggregates cultured for 5 days (C), and co-
aggregates with OP9s cultured for 7 days (D).
SCF, IL3, FLT3LG 50–100 ng/mL were added
as indicated in (E). Numbers shown above
the graph indicate the mean fold expansion
of the experiments shown. For (B), n = 3 for
CS16, and n = 2 for CS17, and numbers before
culture are taken from experiments with
different embryos (see Figure 1). For (C) and
(D), all bars are single experiments showing
before and after culture from the same em-
bryo. See also Figures S1 and S3.
(E) The mean fold increase after culture with different culture conditions corresponding to the charts above. *Indicates where the data are
not shown on the above graphs. Here, three experiments only were performed with CS17 embryos. Error bars show SEM. ee, embryo
equivalent. CS, Carnegie stage.
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Cells in the Early Human Embryo, Stem Cell Reports (2019), https://doi.org/10.1016/j.stemcr.2019.03.003by livers fromCS15 to CS17with progressive appearance of
mixed colonies (CFU-MIX) representing more immature
progenitors (Figure 1). This was not observed in other
tissues including the AGM region.
Establishing a Human AGM Explant Culture System
For the explant culture, AGM regions were dissected and
cultured for 7 days in the presence of 100 ng/mL SCF (Fig-
ure 2), based on its efficient support of HSC maturation in
the mouse AGM region (Rybtsov et al., 2014). We observed
a 7.7-fold increase (range, 3.3–12.8) in CFU-C numbers
across all CS13-17 AGM explants (n = 7). The number of
CFU-Cs before culture was taken from other independent
experiments since explants cannot be disrupted prior to
culture (Figure 1A). We noted the appearance of CFU-
MIX in cultured AGM regions that were not present beforeculture, suggesting their generation in explants. The
macroscopic appearance of other types of colonies before
and after culture was similar (Figure S1). Explants of other
embryonic tissues (umbilical cord, yolk sac, liver) also
showed expansion of CFU-Cs ranging from a mean fold
change of 5 for the umbilical cord to 11 for the yolk sac
across all experiments (Figure S3).
We next tested whether human HSCs could mature in
the AGMculture. BetweenCS14 andCS17, the AGM region
contains 1 definitive HSC, which can provide long-term
multilineage hematopoietic engraftment in NSG mice
upon transplantation (Ivanovs et al., 2011). Initial inde-
pendent experiments (n = 4) were performed using the
whole AGM region or anterior and posterior halves (cut
along the rostra-caudal axis) in the presence of exogenous
SCF (Table 1; Experiments A–D). After 7 days of culture,Stem Cell Reports j Vol. 12 j 1–13 j May 14, 2019 3
Table 1. Analysis of Long-Term Repopulation of NSG Mice by Cultured Human AGM
CS AGM Region Conditions Embryonic Equivalent/Mouse No. Engrafted/No. Injected
Initial Experiments
A 15 Anterior SCF 300 0.14 0 + 3a/3
Posterior SCF 0.14 0 + 3a/3
B 16 Anterior SCF 0.5 1/2
Posterior 0.5 0/2
C 17 Anterior SCF, TGF-bi, ROCKi 0.28 0 + 3a/3
Posterior SCF 0.28 3/3
D 17 Whole AGM SCF, TGF-bi, ROCKi 0.15 1/6
Mapping Experiments
E 13 Part 1 SCF 0.96 0/1
Part 2 0.96 1b/1
Part 3 0.96 0/1
Part 4 0.96 0/1
F 16 Part 1 SCF 0.96 0/1
Part 2 0.96 1/1
Part 3 0.96 1/1
Part 4 0.96 0/1
G 16 Part 1 SCF 0.3 0/2
Part 2 0.3 1 + 1a/2
Part 3 0.3 1/3
Part 4 0.3 0/3
H 16 Part 1 SCF 0.3 0/3
Part 2 0.3 2a/3
Part 3 0.3 0/2
Part 4 0.3 0/3
I 17 Part 2 SCF 0.3 1 + 1a/2
Part 3 0.3 1/1
Part 4 0.3 1/2
The number of repopulated NSG mice relative to the number of mice injected and analyzed are shown. For example, 1 + 1a/2 means one of the two mice
injected had long-term multilineage repopulation at >1%; in the other mouse low-level engraftment was detected. Parts 1–4 are described in Figure S2
and experiments correspond to those in Tables 2 and 3. The embryo equivalent (ee) received by each mouse refers to the ee of each part of the AGM region.
SCF is 100 ng/mL unless stated as 300 (ng/mL), TGF-b inhibitor 5 mM, ROCK inhibitor 10 mM, FLT3LG 100 ng/mL. CS, Carnegie stage. TGF-bi, TGF-b inhibitor.
ROCKi, ROCK inhibitor.
aLow level (<1%) engraftment in bone marrow.
bFull multilineage analysis not performed.
Please cite this article in press as: Easterbrook et al., Analysis of the Spatiotemporal Development of Hematopoietic Stem and Progenitor
Cells in the Early Human Embryo, Stem Cell Reports (2019), https://doi.org/10.1016/j.stemcr.2019.03.003AGM explants were dissociated and injected intravenously
into irradiated NSG mice. Every 1–2 months post trans-
plantation, the peripheral blood of recipient animals was4 Stem Cell Reports j Vol. 12 j 1–13 j May 14, 2019assessed for donor-derived hematopoietic contribution
using a combination of anti-mouse and anti-human
CD45 antibodies. Multilineage engraftment was assessed
Please cite this article in press as: Easterbrook et al., Analysis of the Spatiotemporal Development of Hematopoietic Stem and Progenitor
Cells in the Early Human Embryo, Stem Cell Reports (2019), https://doi.org/10.1016/j.stemcr.2019.03.003in blood, bone marrow, and spleen at least 3 months post
transplantation. From a total of 22 recipients, five were re-
constituted with >1% human CD45+ cells and nine recipi-
ents had only low level (<1%) of bonemarrow engraftment
with no engraftment in peripheral blood. In one variant
included in these experiments, one cultured posterior
half of a CS17 AGM region showed >1% engraftment of
three recipients, which is more than is expected before cul-
ture (Table 1, Experiment C). In two of the experiments
with CS17 AGM regions, we used transforming growth
factor b (TGF-b) inhibitor (5 mM) and ROCK inhibitor
(10 mM) as these might improve the outcome, but these
cultures showed no clear benefit compared with SCF only
cultures (Table 1, Experiments C and D). Overall, the fre-
quencies of repopulation showed that in contrast to mouse
AGM culture systems, human AGM explants failed to
support HSC maturation (expansion), but rather showed
maintenance of solitary definitive HSCs pre-existing in
fresh AGM region (Ivanovs et al., 2011). It is unclear
whether one case of repopulation of three recipients by a
single half of cultured CS17 AGM region (Table 1, Experi-
ment C) was a result of unusually high contents of defini-
tive HSCs (three or more) in the fresh tissue, or because
in this particular case some HSC maturation occurred.
Explants of other embryonic tissues obtained from the
same embryos (yolk sac, umbilical cord, and vitelline ar-
teries) have not shown the presence of definitive HSCs after
transplantation into NSG mice (cultures in the presence of
SCF, TGF-b inhibitor, ROCK inhibitor, and/or FLT3 ligand
[FLT3LG]) (Table S1). For cultured explants of embryonic
livers, three of three NSG recipients had low-level bone
marrow engraftment in two independent experiments
(Table S1, Experiments C and H, CS16 and CS17), and in
one independent experiment, long-term multilineage was
observed (CS17) (Table S1, Experiment I), suggesting the
possible beginning of liver colonization at this stage.
Hematopoietic Capacity of Self-Reaggregate and
Co-aggregate Cultures
Self-reaggregate and co-aggregate cultures of the AGM re-
gion have been a powerful method for analysis of mecha-
nisms underlying HSC development in the mouse AGM
region (Rybtsov et al., 2011, 2014; Souilhol et al., 2016;
Taoudi et al., 2008). Here, for the self-reaggregate cultures,
single-cell suspensions of CS14–17 AGM regions were reag-
gregated (105 cells/reaggregate) and cultured in the pres-
ence of SCF, interleukin 3 (IL3), FLT3LG (50 ng/mL each)
for 5 days. In contrast to explants, dissociation of cells
enabled multiple aliquots to be prepared from one embryo
and therefore direct comparison of CFU-C numbers in
fresh tissues and after culture. Similar to explant cul-
tures, CFU-C numbers increased 7.7-fold (range, 3.2–12.4)
(Figure 2C).For co-aggregate cultures, 105 AGM cells obtained from
CS12–17 AGM regions were aggregated with 105 OP9 cells
and cultured with SCF and IL3 (100 ng/mL each) for 7 days.
We observed an 18.6-fold increase (range, 8.0–31.1) in
CFU-C numbers after 7 days in co-aggregates across all ex-
periments, which is higher than with both self-reaggregate
and explant cultures (Figures 2D and 2E).
We then performed eight independent experiments
where CS12–17 AGM regions were self-reaggregated and af-
ter being cultured for 7 days, were transplanted into irradi-
ated NSG recipients. Only in one experiment were we able
to detect long-term repopulation (data not shown). In a
further six independent experiments, we performed co-ag-
gregation of the CS12–17 AGM region with OP9s for 7 days
in the presence of exogenous SCF and IL3 100 ng/mL.
None of the experiments gave long-term hematopoietic
reconstitution of NSG mice after transplantation (data
not shown).
Definitive HSCs Are Localized Mainly to the Central
Portion of the Human AGM Region
HSCs are known to emerge from the ventral side of the
dorsal aorta (Ivanovs et al., 2014) but their more precise
location along the rostro-caudal axis remains unknown.
To clarify this, the AGM region was sub-dissected into
four parts along the rostro-caudal axis as outlined in Fig-
ure S2. Part 1 was cut above the urogenital ridges (UGRs)
and included the aortic bifurcation. Part 2 was cut
from above the vitelline artery/superior mesenteric artery
(VA/SMA) to the rostral border of the UGRs (the superior
mesenteric artery is a derivative of the vitelline artery
and supplies the mid gut; Schoenwolf et al., 2014). Part 3
was cut above the umbilical artery (UA) entry points and
included the VA/SMA, and part 4 included the UA entry
points and aorta below. Each sub-section of the AGM re-
gion was cultured as an explant in the presence of SCF
100 ng/mL and after 7 days transplanted into irradiated
adult NSG recipients.
In four of these five independent ‘‘mapping’’ experi-
ments, HSCs could be detected in AGM regions after cul-
ture (Table 1, Experiments E–I). In all successful experi-
ments, HSCs were found in parts 2 and 3, i.e., around and
above the VA/SMA limited by the rostral border of the
UGRs. In one of these experiments, an additional HSC
was also found in part 4, around the UA entry points. Inter-
estingly, it seems that we had a slight expansion of HSC
numbers in these experiments. Three of four cultured
CS16–17 AGM regions contained two or three HSCs, which
is higher than expected in fresh AGM regions (Ivanovs
et al., 2011). Similarly, we have been able to detect the
appearance of a definitive HSC after transplantation of
part 2 of a CS13 embryo, which has not previously been
detectable in the AGM region at this stage.Stem Cell Reports j Vol. 12 j 1–13 j May 14, 2019 5
Figure 3. Relative Spatial Distribution of
CFU-Cs and HSCs from the Human AGM
after Culture
Mapping experiments demonstrating the
location of HSCs and CFU-Cs in each of four
parts of the AGM (see Figure S2) after 7 days
of explant culture with addition of SCF
100 ng/mL are shown. Numbers and types of
CFU-Cs are shown along with the Carnegie
stage (CS) of each independent experiment.
The corresponding number of mice with
long-term multilineage engraftment relative
to the number of mice injected is shown for
each part of the AGM. The repopulated mice
correspond to those shown in Tables 1, 2,
and 3. ee, embryo equivalent; UAs, umbilical
arteries; VA/SMA, vitelline artery/superior
mesenteric artery. See also Figure S2.
Please cite this article in press as: Easterbrook et al., Analysis of the Spatiotemporal Development of Hematopoietic Stem and Progenitor
Cells in the Early Human Embryo, Stem Cell Reports (2019), https://doi.org/10.1016/j.stemcr.2019.03.003To establish the relative location of CFU-C production
in the AGM region, a small aliquot, no greater than 0.1
embryo equivalent (ee), was taken from the single-cell sus-
pension made from embryonic tissues 7 days after culture
(the rest was used for transplantations into NSG mice as
described above; Table 1). The aliquot was used for the he-
matopoietic CFU-C assay. Results from six independent
experiments from CS13–17 are shown in Figure 3. Parts
2 and 3 contained the highest numbers of CFU-Cs in all6 Stem Cell Reports j Vol. 12 j 1–13 j May 14, 2019six experiments (range, 780–4,600), except for the CS13
experiment where part 1 was found to have the most
CFU-Cs. HSCs were also consistently present in parts 2
and 3 (Figure 3 and Table 1). In all six experiments, the
lowest CFU-C numbers (%210 per 1 embryo equivalent
[ee]) were detected around the UA entry points. Thus,
the location of the highest CFU-C numbers correlated
with the positions in which HSCs were detected. In all ex-
periments, except CS13 analysis, mixed colonies were
AB
C
Figure 4. Explant Culture Maintains HSCs with Long-Term
Multilineage Repopulating Capacity In Vivo
(A) Kinetics of human hematopoietic repopulation in the peripheral
blood for 14 NSG mice transplanted with cultured human AGM (solid
lines) or embryonic liver (EL) (dotted line).
Please cite this article in press as: Easterbrook et al., Analysis of the Spatiotemporal Development of Hematopoietic Stem and Progenitor
Cells in the Early Human Embryo, Stem Cell Reports (2019), https://doi.org/10.1016/j.stemcr.2019.03.003found after culture in addition to myeloid and erythroid
colonies (Figure 3).
Explant Culture Maintains HSCs with Long-Term
Multilineage In Vivo Repopulating Capacity
In NSG mice repopulated with cultured human AGM,
engraftment could first be detected in the peripheral blood
of mice at around 8 weeks (0.14% ± 0.1%), and in most
there was a notable rise in engraftment level at 4–5months
(Figure 4A). Levels of engraftment ranged from 1.6%
(12 weeks) to 49.7% (17 weeks) in the bone marrow,
0.1% (12 weeks) to 10% (17 weeks) in the blood, and
0.4% (12 weeks) to 20.8% (20 weeks) in the spleen (Table
2). The one NSG recipient successfully engrafted with
cultured embryonic liver had relatively higher engraftment
at 21weeks comparedwith those transplantedwith the hu-
man AGMwith 22% in blood, 23.4% in bone marrow, and
23.9% in the spleen (Table 2). As expected, across all
samples, human multilineage hematopoietic repopulation
generally displayed a B lymphoid bias in engrafted NSG
mice (Ivanovs et al., 2011; Shultz et al., 2005; Theocharides
et al., 2016). Human CD19+ B cells were the major human
leukocyte population in the peripheral blood (55% ± 18%)
and spleen (58% ± 24%). However, in the bonemarrow, the
major human leukocyte population was more variable, in
some mice being B lymphoid-biased (9/13 mice; mean,
52% ± 24%) and in others myeloid-biased (4/13 mice;
mean, 37% ± 22%) (Table 3, Figures 4B and S4). Human
CD33+CD66b+ granulocytes and CD33+CD14+ macro-
phages were also detected in blood, bone marrow, and
spleen of engrafted NSG mice (Table 3, Figures 4B, 4C,
and S4). The level of human CD3+ T cells and CD94+
NK cells was particularly variable, as had been seen with
the transplantation of fresh AGM into NSG mice
(Ivanovs et al., 2011). Human immunophenotypic HSCs(B) Representative flow cytometry plots of human myeloid
(CD45+CD33+), T (CD45+CD3+), B (CD45+CD19+), NK (CD45+CD94+)
cells in the peripheral blood, bone marrow, and spleen of an NSG
mouse transplanted with 0.3 ee of a cultured CS16 human AGM
region (part 2), culled for analysis at 7 months.
(C) Representative flow cytometry plots of HSCs (CD34+CD38
CD90+CD45RA), multipotent progenitors (MPPs) (CD34+CD38
CD90CD45RA), and multi-lymphoid progenitors (MLPs) (CD34+
CD38CD90CD45RA+) (i), erythroid cells (ii), myeloid cells (iii),
NK/NKT cells (iv), and T cells (v) in the bone marrow, blood, spleen,
and thymus of NSG mice. (i), (ii), and (v) are from a primary
recipient mouse injected with 0.96 ee of AGM part 3 from a CS16
embryo cultured for 7 days, culled for analysis at 4 months. (iii) and
(iv) are taken from a primary recipient mouse injected with 0.28 ee
AGM posterior half, from a CS17 embryo cultured for 7 days, culled
for analysis at 5 months.
All plots are gated on 7AAD singlets. Flow cytometry controls are
shown in Figure S4. BM, bone marrow.
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Table 2. Level of Repopulation in Mice Engrafted by Cultured Human Embryonic HSCs
Experiment No. (CS) AGM Region Time after Transplantation (Weeks)
% Human CD45+ Cells
Blood Bone Marrow Spleen
B (16) Anterior 17 10.0 49.7 7.7
C (17) Posterior 20 2.2 16.8 20.8
20 1.3 3.3 7.5
20 6.4 32 10.5
D (17) Whole 12 0.1 1.6 0.4
E (13) Part 2 19 0.3 41.1 8.3
F (16) Part 2 16 0.9 15.7 0.6
Part 3 16 2.6 27.2 3.1
G (16) Part 2 27 1.6 15.8 3.3
Part 3 33 1.5 10.8 5.6
I (17) Part 2 21 3.0 22.4 6.8
Part 3 21 2.7 12.1 2.8
Part 4 21 2.8 10.8 2.9
Liver 21 22.0 23.4 23.9
The level of repopulation of engrafted mice only is shown and corresponds to the engrafted mice indicated in bold in Table 1. (For example, Part 1 never gave
engraftment, hence is not seen in this table). Parts 1–4 are described in Figure S2 and experiments correspond to those in Tables 1 and 3. The NSG mouse
engrafted with embryonic liver is included for completeness. CS, Carnegie stage.
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tors (MPPs) (CD34+CD38CD90CD45RA), and multi-
lymphoid progenitors (MLPs) (CD34+CD38CD90
CD45RA+) could be identified in the recipient bonemarrow
(Figure 4C) (Doulatov et al., 2010; Majeti et al., 2007),
constituting 12% ± 4%, 13% ± 4%, 23% ± 7% of
CD34+CD38 cells, respectively. Comparing these propor-
tions with human bone marrow (BM) and cord blood
(Doulatov et al., 2010; Majeti et al., 2007), MLPs were the
dominant population of hematopoietic progenitors in
the recipient BM rather than MPPs.DISCUSSION
The AGM region is the major site of HSC development in
mammals. The first HSCs emerge in low numbers (as single
cells), both in the mouse and human dorsal aorta (Ivanovs
et al., 2011; Kumaravelu et al., 2002; Mu¨ller et al., 1994). It
had previously been shown that the first HSCs emerge from
the ventral side of the dorsal aorta at CS14–17 in the hu-
man embryo (Ivanovs et al., 2014). However, their more
precise location along the rostral-caudal axis and relation-
ship to CFU-Cs remains unexplored. In addition, the devel-
oping human HSC hierarchy has yet to be established.8 Stem Cell Reports j Vol. 12 j 1–13 j May 14, 2019While an ex vivo culture system has facilitated recapitula-
tion of HSC development in the mouse and been pivotal
in our understanding of the mouse developmental HSC
hierarchy, this system has not yet been translated into hu-
man studies (Rybtsov et al., 2011, 2014; Souilhol et al.,
2016; Taoudi et al., 2008). We therefore sought to advance
understanding of early human hematopoietic develop-
ment by temporal and spatial characterization of CFU-Cs
and HSCs through adaption of the murine ex vivo culture
system for the human AGM region. A previous study
described the distribution of CFU-Cs in the extra-hepatic
embryo but did not specifically describe CFU-Cs in the
AGM (Huyhn et al., 1995).
We observed significant numbers of CFU-Cs initially in
the yolk sac from CS12. Meanwhile, the AGM region was
only gradually accumulating CFU-C numbers in line with
the role of the yolk sac in the colonization of the AGM re-
gion established for the mouse (McGrath et al., 2015; Palis
et al., 1999). Interestingly, we observed a sharp rise in
CFU-C content in the liver beginning from CS15, consis-
tent with previous studies (Huyhn et al., 1995; Tavian
et al., 1996, 1999). It is not currently clear whether it is
related to changes in CFU-C properties or critical develop-
ment of the liver stroma. Notably, we observed the
appearance of immature CFU-MIX in the liver from CS16,
Table 3. Multilineage Hematopoietic Engraftment in Primary Recipient Mice
Experiment No. (CS) Tissue
Blood (%) Bone Marrow (%) Spleen (%)
Myeloid B T NK Myeloid B T NK Myeloid B T NK
B (16) Anterior 28 30 40 0 8 90 0.3 0.2 3.9 88.2 0.7 0.1
C (17) Posterior 29 69 0 0 42 47 1.5 0 32 62 5 0.5
25 70 0 0 43 47 3.9 0.6 9 78 1.3 1.4
7 45 45 2 34 52 8 4 30 8 60 1
D (17) Whole NA NA NA NA 56 33 1 0 22 43 0 0
F (16) Part 2 8 61 30 0 23 75 1.5 0.1 26 69 0.9 3
Part 3 20 46 NA 0 30 69 0.7 0 20 NA NA NA
G (16) Part 2 51 39 2 0 68 26 0.1 0.3 33 55 7 3
Part 3 33 17 33 12 82 12 0.3 0.9 33 49 7 7
I (17) Part 2 10 72 11 2.3 23 68 1.0 0.7 6 79 10 3.6
Part 3 36 47 1.4 0.8 31 61 1 0.8 10 84 1.4 0.8
Part 4 16 61 2.0 7 18 70 1.3 0.1 9 85 0.7 0
Liver 12 22 48 17 70 18 12 2.6 18 38 43 10
Percentage of myeloid cells (CD33+), B cells (CD19+), T cells (CD3+), and NK cells (CD94+) in the human CD45+ cell population in the peripheral blood, bone
marrow, and spleen of repopulated primary recipient NSG mice is shown. Only repopulated mice are shown and correspond to engrafted mice indicated in
Tables 1 and 2. The NSG mouse engrafted with embryonic liver is included for completeness. NA, not assessed.
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the role of the liver in the development of definitive hema-
topoiesis. Future analysis will be needed to determine what
proportion of CFU-Cs circulating during these stages are
erythro-myeloid progenitors (McGrath et al., 2015) and
which of them aremultipotent ones with lymphoid poten-
tial. Based on analysis of the mouse model, we can assume
that the human AGM region contains a number of imma-
ture precursors of definitive HSCs (Rybtsov et al., 2011,
2014; Taoudi et al., 2008). In line with that, AGM cultures
start producing CFU-MIX, which are absent in the fresh
tissue.
HSC precursors are unable to engraft when directly trans-
planted into an adult recipient, but can engraft when al-
lowed to mature in culture to become HSCs. Our adaption
of the murine ex vivo culture system failed to convincingly
reveal HSC precursors but has hinted at their existence. We
established that up to three HSCs can be detected after
7 days of explant culture of the human AGM region, which
at least matches and potentially surpasses the one or two
HSCs detected in the fresh AGM region (Ivanovs et al.,
2011). Hence, definitive HSCs from the human AGM can,
at least, bemaintained ex vivo. In each of ten previous inde-
pendent experiments, we detected one HSC per fresh AGM
region (except one experiment when two HSCs were
found) (Ivanovs et al., 2011). In the current experiments,we frequently detected at least two HSCs per AGM region,
suggesting some limited maturation of HSC precursors in
the explant culture system. Indeed, it seems unlikely that
this slight effect was due to self-renewal of pre-existing
definitive HSCs, since after culture, HSCs were generally
present in separate AGM sub-sections. Although experi-
ments directly comparing cultured and uncultured AGM
would have helped to answer whether the culture system
did indeed mature any precursors of HSCs, such experi-
ments are not possible due to the scarcity of human embry-
onic tissue. Although the aggregate culture system could
address this issue, we found no repopulation after aggre-
gate culture of human AGM region.
HSCs derived from explant cultured human embryonic
tissue provided long-term multilineage repopulation of
NSGmice as was observed with fresh AGM region (Ivanovs
et al., 2011). Variability in the distribution of lineages en-
grafted was detected, in line with our previously reported
transplantation of AGM region cells directly into NSG
mice (Ivanovs et al., 2011). This may reflect individual dif-
ferences in the repopulating capacity of NSG mice or the
lineage bias of individual HSCs transplanted. Proportions
of progenitor populations in the BM of repopulated mice
differed from those previously reported for fresh BM and
cord blood (Doulatov et al., 2010; Majeti et al., 2007).
Again, further work would be required to investigateStem Cell Reports j Vol. 12 j 1–13 j May 14, 2019 9
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onic HSCs, the repopulating capacity of NSGmice, or both.
It was noted that the absolute levels of human engraftment
reported here were slightly lower than those previously re-
ported for human AGM directly transplanted into NSG
mice without being cultured (Ivanovs et al., 2011). Given
the time between the studies, this may reflect many vari-
ables, including the individual NSG mice. However, it
could reflect a real reduction in the repopulating capacity
of the HSCs after culture.
In terms of spatial distribution, this study has shown that
HSCs are chiefly located around and above the vitelline ar-
tery entry point to the rostral end of UGRs. HSCs in the E11
mouse AGM region were also found to be enriched in the
middle portion of the aorta, near the junction of the dorsal
aorta and vitelline artery (Mascarenhas et al., 2009).
Notably, these AGM portions possess the capacity to pro-
duce large numbers of CFU-Cs in our experiments. It is
also interesting that this area of the human AGM region
is known to be enriched for IAHCs (Tavian et al., 1996,
1999). Nonetheless, correlation between IAHCs and HSC
activity is not direct; by CS17, IAHCs largely disappear,
while HSCs are still detectable (Ivanovs et al., 2011; Tavian
et al., 1999). Here, we show that CFU-C productivity in the
AGM region increased in a linear manner throughout
CS12–17, while the IAHCs decline by CS17. This may be
due to migration of progenitors from the yolk sac via the
vitelline artery and colonization in the AGM region. How-
ever, further work would be required to examine this
hypothesis.
This work poses the question of why this ex vivo culture
system does not facilitate the large-scale maturation and
expansion of human HSCs seen for mouse HSCs, given
the robustness of the mouse AGM culture system. The
most likely explanation is that the culture system has not
been optimized. Given the significantly longer timescale
of human development (Ivanovs et al., 2017), HSCmatura-
tionmay require more than the 7 days that we were testing
in these experiments. Additionally, here we chose factors
based on mouse ex vivo culture studies (Robin et al., 2006;
Taoudi et al., 2008). In spite of significant conservation of
hematopoietic development across vertebrate species,
there might be differences in requirement of cytokines be-
tween mouse and human.
In summary, we established that human AGM-derived
definitive HSCs can be maintained and on rare occasions
mature from HSC precursors in culture. This work
enhanced our understanding of the spatial development
of HSCs, localizing them predominantly to the portion of
the AGM region around and above the vitelline artery,
which shows high CFU-C productivity, and which are en-
riched for intra-aortic clusters. Our study highlights impor-
tant differences in the biology of human and murine10 Stem Cell Reports j Vol. 12 j 1–13 j May 14, 2019embryonic hematopoietic development, which are yet to
be unraveled.
We believe the search for conditions to support hu-
man HSC development in human AGM culture should
continue, as this would greatly assist the derivation of
transgene-free clinically applicable HSCs from human
embryonic/induced pluripotent stem cells.EXPERIMENTAL PROCEDURES
Processing of Human Embryonic Tissue
Human embryos were obtained immediately after elective termi-
nation of pregnancy either from the Royal Infirmary of Edinburgh
(RAA/FT study, approved by the Lothian Research Ethics Commit-
tee, Reference: 08/S1101/1) or from the MRC-Wellcome Trust
Human Developmental Biology Resource (HDBR), Institute of Ge-
netic Medicine, Newcastle. All patients donating tissue had given
informed written consent for the use of human embryonic tissues
in research prior to tissues being obtained and anonymized. The
developmental stage of human embryos was determined by the
CS system (Ivanovs et al., 2013; O’Rahilly and Muller, 1987).
Dissectionswere performed under a low power stereomicroscope
(Leica MZ8) in sterile dissection buffer (Dulbecco’s phosphate
buffered saline [PBS] withMg2+ and Ca2+ ions [Sigma-Aldrich] con-
taining 7% fetal calf serum [FCS] [Thermo Fisher Scientific or APS],
100 IU/mL penicillin and 100 mg/mL streptomycin [Invitrogen]).
Where possible, the AGM region, yolk sac, umbilical cord, vitelline
vessels, and liver were obtained from each embryo. However, due
to damage to the embryo prior to obtaining them, it was not always
possible to harvest all tissues. Further sub-dissection of theAGMre-
gion is described in the Results. Images of human tissue were taken
using a Leica MZ FLIII with DFC7000T camera (Leica). Embryonic
tissues were dissociated to single-cell suspensions in 5 mL polysty-
rene tubes (BD Falcon). For this, 800 mL of dissection buffer was
used with 100 mL of 10 mg/mL collagenase-dispase (Roche) and
100 mL of 1.2 mg/mL DNase I (Roche) and incubated at 37C for
40 min with gentle shaking in a water bath. The dissociation was
stopped by adding 4 mL of dissociation buffer (Dulbecco’s PBS
without Mg2+ and Ca2+ [Sigma-Aldrich] containing 7% FCS and
100 IU/mL penicillin and 100 mg/mL streptomycin), centrifuga-
tion at 350 3 g for 5 min at 4C and resuspending in flow cytom-
etry buffer (Dulbecco’s PBS without Mg2+ and Ca2+ containing 2%
FCS with or without 100 IU/mL penicillin and 100 mg/mL strepto-
mycin) in a suitable volume for further analysis or culture. The
number of cells was quantified as embryo equivalents. ‘‘Indepen-
dent’’ experiments refers to those performed with different human
embryos.Human Embryo Culture System
Human embryonic tissues were cultured both as explants and ag-
gregates in Costar tissue culture 6-well plates in embryo culture
medium (Iscove’s modified Dulbecco’s medium [IMDM; Gibco],
20% pre-selected heat-inactivated Hyclone FCS [Thermo Fisher
Scientific], L-glutamine [4 mM, Invitrogen], 100 IU/mL penicillin
and 100 mg/mL streptomycin). The culture was performed at the
liquid-gas interface on 0.8-mm nitrocellulose filters (Millipore)
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less otherwise stated. The medium was changed at 24 h then left
for a further 6 days. For explants, each embryonic tissue was
placed on its own membrane immediately after dissection. For
the aggregate system, both self-reaggregates and co-aggregates
with OP9s were made. In both cases, a single-cell suspension of
the tissue was first obtained as described above. OP9 cells were
maintained in IMDM (Invitrogen), 20% FCS supplemented with
L-glutamine (4 mM), penicillin/streptomycin (50 U/mL) and
passaged every 4–5 days. They had previously been maintained
in the Medvinsky group. Where co-aggregates were being made,
OP9 stromal cells were first obtained by trypsinization and mixed
with a single-cell suspension of embryonic tissue (1 3 105 OP9s +
1 3 105 human embryonic cells/aggregate). For self-reaggregates,
1 3 105 embryonic cells were used per aggregate. Two to three ag-
gregates were placed on each membrane. Reaggregates or co-ag-
gregates were formed by centrifugation of cell suspensions at
440 3 g for 12 min in 200-mL pipette tips sealed with parafilm
to form a pellet (Taoudi et al., 2008). Experimental variables for
the culture medium included addition of human SCF 100–
300 ng/mL (catalog no. 300-07), IL3 100 ng/mL (catalog no.
200-03), FLT3LG 100 ng/mL (catalog no. AF-300-19) (all Pepro-
tech), TGF-b inhibitor (SB 431542) 5 mM (Tocris, catalog no.
1614), ROCK inhibitor Y-27632 10 mM (Sigma-Aldrich, catalog
no. SCM075). Details are described in the Results section. Both
explants and aggregates were harvested and dissociated with
collagenase/dispase as outlined for fresh embryonic tissues and
used for further analysis.In Vivo Long-Term Repopulation Assay
NOD.Cg-Prkdcscid Il2rgtm1Wjl (NSG) mice were used as recipi-
ents of human cells. All experiments with animals were performed
under a project license granted by the Home Office (UK), Univer-
sity of Edinburgh Ethical Review Committee, and conducted in
accordance with local guidelines. Animals were bred and housed
within the University of Edinburgh under the regulations of the
Animals Scientific Procedures Act, UK, 1986. The NSG mice were
housed in pathogen-free conditions in individually ventilated ca-
ges or isolators. They received autoclaved drinking water, auto-
claved bedding, and g-irradiated chow diet. For the first 4 weeks af-
ter irradiation, their autoclaved drinking water was supplemented
with 0.1mg/mL of enrofloxacin (10%Baytril solution from Bayer).
All mice were exposed to a constant cycle of 14 h of light/10 h of
dark. Up to 6 h prior to transplantation with human cells, 6- to
8-week-old NSGmice received a sublethal dose of total body irradi-
ation (3.3 Gy at a rate of 0.75 Gy/min from a 137Cs source [GSR D1
g-irradiator, Gamma-Service Medical]). Animals were transplanted
with cells intravenously via the lateral tail vein in up to 200 mL us-
ing a 26-gauge syringe needle (BD Microlance), according to the
procedures described in the project license and the regulations of
the Animals Scientific Procedures Act, UK, 1986. Where human
embryonic tissue was used, the quantity of human embryonic tis-
sue transplanted is expressed in embryo equivalents, which is the
number of cells present in a whole or specified part of an embryo of
that stage.
As a positive control for selected experiments, 4 3 104 UCB
CD34+ cells were injected intravenously. Human UCB sampleswere obtained from full-term umbilical cord after elective cesarean
sections from the Edinburgh Reproductive Tissue Biobank. This
study was approved by the Lothian Research Ethics Committee
(reference, 16/SS/0220). All patients donating tissue had given
informed written consent for the use of human tissues in research
prior to tissues being obtained and anonymized. Erythrocytes were
lysed with BD Pharm Lyse Buffer (BD Biosciences). CD34+ cells
were sorted by magnetic cell separation using CD34 microbeads,
a QuadroMACS separator, and LS columns (MACSMiltenyi Biotec)
according to the manufacturer’s instructions. After selection, cells
were stored at 150C.
To detect long-term hematopoietic repopulation, NSG recipient
mice were bled every 1–2 months starting from 6–8 weeks after
transplantation. Their tail vein was nicked and 2–3 drops collected
into flow cytometry buffer supplemented with 5 mM of EDTA
(VWR International). Red cells were lysed using BD Pharm Lyse
Buffer (BD Biosciences) diluted 1:10 with water, and flow cytome-
try was performed to assess for human engraftment with anti-hu-
man CD45 antibody. Experiments were ended at 3–8 months after
transplantation. All recipientmicewere killed by dislocation of the
neck according to Schedule 1 of the Animal (Scientific Procedures)
Act 1986, and their BM (long bones), spleen, and thymuswere har-
vested. Spleen and thymus were gently mashed in a small volume
of buffer through a 40 mmEASYstrainer (Greiner Bio-One). The BM
was flushed out from the bones, and a single-cell suspension was
prepared by gentle pipetting. Cell suspensions of BM, thymus,
and spleen were analyzed by flow cytometry to detect long-term
multilineage engraftment. Engraftment with human hematopoi-
etic tissues was defined as >1% human CD45+ cells in the BM
with human cells also detectable in the blood and spleen by flow
cytometry. Engraftment data are stated in the text as mean ±
standard deviation.Human Colony-Forming Cell Assay
The colony-forming cell assay (CFU-C assay) was used to detect he-
matopoietic progenitor numbers. Cells were plated in at least
duplicate for all independent experiments, and the mean score
was used for analysis. All graphs show means of independent ex-
periments, i.e., biological not technical variance, rounded to the
nearest 5 CFU-Cs. To detect CFU-C number in dissociated human
embryonic tissue, 0.1–0.005 ee of cells were plated into 1.5 mL of
MethoCult H4034 Optimum Medium (STEMCELL Technologies)
in 30 mm untreated tissue culture dishes. Cells were incubated at
37C in 5% CO2. Hematopoietic colonies were counted, scored,
and photographed after 10–14 days.Flow Cytometry
Antibody staining was performed in 5 mL polystyrene tubes (BD
Falcon) or in U-bottomed 96-well plates (Sterilin). For flow cy-
tometry analysis, the following mouse anti-human monoclonal
antibodies were used: CD3-APC (clone SK7, eBioscience), CD4-
APC (clone RPA-T4, BD Biosciences), CD8-PE (clone RPA-T8, BD
Biosciences), CD14-APC (clone M5E2, BD Biosciences), CD19-
PE (clone HIB19, eBioscience), CD33-PE (clone WM53, BD
Biosciences), CD34-APC (clone 8G12, BD Biosciences), CD38-
FITC (clone HIT2, BD Biosciences), CD45-FITC (clone H130,
eBioscience), CD45RA-efluor450 (clone HI100, eBioscience),Stem Cell Reports j Vol. 12 j 1–13 j May 14, 2019 11
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5E10, BD Biosciences), CD94-APC (clone HP-3D9, BD Biosci-
ences), CD235a-APC (clone GA-R2, BD Biosciences), and the rat
anti-mouse monoclonal antibody, CD45-APC (clone 30-F11,
eBioscience). The concentration used was as per the manufac-
turer’s instructions or determined by in-house titration. Flow cy-
tometry buffer was used for staining and washes. To prevent
unwanted binding of antibodies to Fc receptors, cells were resus-
pended in 25 mL of human FcR Blocking Reagent (Miltenyi
Biotec) and anti-mouse CD16/32 purified monoclonal antibody
(eBioscience) diluted 1:10 and 1:200, respectively, in flow cytom-
etry buffer and incubated on ice for 10 min. Then 25 mL of
antibody solution at the double concentration was added to the
cells, making the final cell suspension volume 50 mL. Primary
antibodies were incubated with cell suspensions for 30 min on
ice in the dark prior to two washes. Cells were resuspended
in flow cytometry buffer supplemented with 1.5 mg/mL of
7-amino-actinomycin (7-AAD) (eBioscience) for flow cytometry
analysis. In parallel, control samples were stained with FMO
(fluorescence minus one), in which all antibodies were added
except for one. In addition, single stains for each antibody were
prepared with cells, BD CompBeads Set Anti-Mouse Ig,k (BD Bio-
sciences) or UltraComp eBeads (eBioscience). Flow cytometry
analysis was performed using a FACSCalibur (BD Bioscience) or
BD LSR Fortessa analyzer (5 laser or 4 laser) (BD Bioscience).
Compensation adjustments were made based on appropriate
single stains, and gates were defined by FMO controls or isotype
controls. Forward and side scatter profiles were used to assess cell
size and granularity to gate cells of interest and exclude doublets.
Live cells were gated according to low uptake of 7AAD. Flow
cytometry data were analyzed with FlowJo v10.2 software (Tree
Star).
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